Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon-enhanced insulin absorption in type 1 diabetes mellitus
2022-502455-57-01Phase 2Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of glucagon in diabetes mellitus type 1 (T1D), sponsored by St. Olavs University Hospital. Primary endpoint: Area under the glucose curve for the first 60 minutes. Started Jun 2023; status: completed.
02
Drugs
glucagon
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2022-502455-57-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502455-57-01.